시장보고서
상품코드
1498724

자가백신 시장 : 제품 유형별, 용도별, 유통별, 기술별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Autogenous Vaccines Market, By Product Type, By Application, By Distribution, By Technology, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 270 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

자가백신 시장 규모는 2023년 1억 3,092만 달러로 2024년부터 2032년까지 CAGR 5.95%로 확대될 것으로 예상됩니다.

자가백신 시장 - 시장 역학

엄격한 규제 프레임워크가 시장 성장을 저해할 가능성

자가백신 산업은 유리한 시장 역학에도 불구하고 지적재산권, 규제 프레임워크, 기술적 한계와 관련된 장애물에 직면해 있습니다. 자가백신은 미국 농무부의 수의학 서비스 지침(Veterinary Service Memorandum Guidelines for Autogenous Biologics)이 적용됩니다. 자가백신은 특별히 제조된 불활성화 백신으로, 수의사 또는 기타 공인된 전문가에 의해서만 접종됩니다. 영국에서 판매되는 동물용 의약품의 유효성, 안전성 및 품질을 보장하는 책임 기관은 수의약국(Veterinary Medicines Directorate)입니다. 면역학 팀은 면역학 제제를 제조하는 시설을 검사하고 면역학 제제의 판매 승인 신청을 평가합니다. 제조 절차는 자가백신의 품질과 시장 가용성에 영향을 미치는 가장 중요한 요소입니다. 제조 절차는 규제 요건에 따라 최적화되어 있습니다.

자가백신 시장 - 주요 인사이트

당사의 연구 분석가들의 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 약 5.95%의 CAGR로 성장할 것으로 예상됩니다.

제품 유형별로는 Bacterial Autogenous Vaccines가 2023년 가장 큰 시장 점유율을 보일 것으로 예상되었습니다.

용도별로는 가축용 백신이 2023년 주요 유형으로 꼽혔습니다.

최종사용자별로는 동물병원이 2023년 주요 유형으로 꼽혔습니다.

유통 부문별로는 직판이 2023년 주요 유형으로 꼽혔습니다.

지역별로는 유럽이 2023년 매출에서 선두를 차지했습니다.

자가백신 시장 - 세분화 분석:

세계 자가백신 시장은 제품 유형, 용도, 유통, 기술, 최종사용자 및 지역을 기준으로 세분화됩니다.

시장은 용도에 따라 가축 백신, 반려동물 백신, 양식 백신 등 세 가지 범주로 나뉩니다. 질병 위협을 효과적으로 관리하기 위해 가축과 가금류 개체수가 많은 대규모 농가는 전문적인 백신 접종 프로그램을 실시해야 합니다. 바이오 보안 프로토콜을 개선하고 지속가능한 농법을 보장하려는 대규모 농장은 특히 맞춤형 예방 접종 전략을 시행할 가능성이 높습니다.

시장은 제품 유형에 따라 세균성 자가백신, 바이러스성 자가백신, 기타의 세 가지 범주로 나뉘며, 2023년 양식어류 자가백신 시장은 세균 분야가 시장의 80% 이상을 차지하며 주도하고 있습니다. 에어로모나스, 연쇄상구균, 비브리오와 같은 박테리아가 질병을 유발하는 경우가 많기 때문에 이러한 문제를 해결하기 위해 특별히 고안된 백신에 대한 수요가 증가하고 있습니다. 자가백신은 특정 양식장에 존재하는 미생물을 퇴치하기 위해 특별히 설계되었기 때문에 독특합니다. 따라서 질병을 막는 데 탁월합니다. 양식업자들은 생산에서 사용까지 빠른 이 백신을 선호하게 되었습니다.

자가백신 시장 - 지리적 인사이트

동물용 생물학적 제제 및 제약 산업의 연구 노력 증가와 동물 건강 관리 관련 비용 증가로 인해 유럽은 현재 자가백신 세계 시장을 주도하고 있습니다. 또한, 동물용 백신의 사용 증가와 동물 건강에 대한 인식이 높아짐에 따라 시장이 확대되고 있습니다. 또한, 아시아태평양은 가장 수익성이 높은 지역 중 하나이며, 국제 기업들에게 기회를 제공하고 있습니다. 이 지역에서는 전염병의 위험 증가와 질병에 걸린 동물의 수가 많기 때문에 자가백신에 대한 수요가 증가할 수 있습니다.

자가백신 시장 - 경쟁 상황:

자가백신 시장의 주요 기업으로는 IDT Biologika GmbH, MARINNOVAC, Ceva Biovac, HIPRA, AniCon Labor GmbH, Kennebec River Biosciences 등이 있습니다. 주요 경쟁사들은 업계 내 입지를 강화하기 위해 제휴, 제품 출시, 인수합병, 사업 확장 등의 전술에 집중하고 있습니다. 예를 들어, Newport Laboratories와 같은 기업들은 더 넓은 고객층에 서비스를 제공하기 위해 제품을 다양화하고 새로운 고객층에 접근하고 있으며, Ceva Sante Animale, Phibro Animal Health, Zoetis와 같은 주요 기업들은 광범위한 연구 및 개발 역량을 보유하고 있습니다. Ceba Sante Animale, Phibro Animal Health, Zoetis와 같은 대형 기업들은 광범위한 연구 개발 능력과 광범위한 판매망을 갖추고 있습니다. 특히 가축 수가 많고 특정 질병 문제가 있는 지역에서는 현지 및 지역 제조업체도 중요한 역할을 담당하고 있습니다. 이들 제조업체는 해당 지역의 질병 유행 상황을 깊이 이해하고 그에 따라 맞춤형 솔루션을 제공하는 경우가 많습니다.

목차

제1장 자가백신 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 자가백신의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 전망 동향

제4장 자가백신 산업 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 매핑
  • 규제 프레임워크 분석

제5장 자가백신 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 자가백신 시장 상황

  • 자가백신 시장 점유율 분석, 2023년
  • 주요 제조업체별 내역 데이터
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 자가백신 시장 : 제품 유형별

  • 개요
    • 제품 유형별 부문 점유율 분석
    • 세균성 자가백신
    • 바이러스성 자가백신
    • 기타

제8장 자가백신 시장 : 용도별

  • 개요
    • 용도별 부문 점유율 분석
    • 가축 백신
    • 반려동물용 백신
    • 수산양식 백신

제9장 자가백신 시장 : 유통별

  • 개요
    • 유통별 부문 점유율 분석
    • 직접 판매
    • 대리점 판매
    • 온라인 판매

제10장 자가백신 시장 : 기술별

  • 개요
    • 기술별 부문 점유율 분석
    • 불활화 백신
    • 생약독화 백신
    • 아단위 백신
    • 톡소이드 백신

제11장 자가백신 시장 : 최종사용자별

  • 개요
    • 최종사용자별 부문 점유율 분석
    • 수의 클리닉
    • 동물 병원
    • 동물농장
    • 수산양식장

제12장 자가백신 시장 : 지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제13장 주요 벤더 분석 : 자가백신 업계

  • 경쟁 대시보드
  • 기업 개요
    • IDT Biologika GmbH
    • MARINNOVAC
    • Ceva Biovac
    • Zoetis(PHARMAQAS)
    • Vaxxinova
    • Barramundi Asia Pte Ltd.(UVAXX Asia)
    • HIPRA
    • AniCon Labor GmbH
    • sanphar(ipeve)
    • Kennebec River Biosciences
    • Others

제14장 애널리스트의 전방위 전망

ksm 24.06.27

REPORT HIGHLIGHT

Autogenous Vaccines Market size was valued at USD 130.92 Million in 2023, expanding at a CAGR of 5.95% from 2024 to 2032.

The rise in infectious diseases among livestock and companion animals drives the demand for autogenous vaccines. These vaccines are crucial for managing outbreaks caused by unique or region-specific pathogens. The ability to customize vaccines to target specific strains in a particular herd or flock increases their effectiveness, making them an attractive option for veterinarians and farmers. The increasing trend of pet ownership and the willingness of pet owners to invest in preventive healthcare for their animals create opportunities for the development and sale of autogenous vaccines for companion animals.

Autogenous Vaccines Market- Market Dynamics

Stringent Regulatory Frameworks Potentially Impede the Market Growth

The autogenous vaccine industry is confronted with obstacles regarding intellectual property rights, regulatory frameworks, and technological limitations, even with its advantageous market dynamics. Regulations and the USDA's Veterinary Service Memorandum Guidelines for Autogenous Biologics apply to autogenous vaccines. These are specially prepared inactivated vaccinations that can only be administered by veterinarians or other authorized professionals. In the United Kingdom, the responsible authority for guaranteeing the effectiveness, safety, and quality of veterinary pharmaceuticals sold is the Veterinary Medicines Directorate. The Immunological team is in charge of inspecting the production facilities that generate immunological products and evaluating immunological applications for marketing authorizations. Manufacturing procedures are the most important factor affecting the quality of autogenous vaccines and their availability on the market. They are optimized by regulatory requirements.

Autogenous Vaccines Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.95% over the forecast period (2024-2032)

Based on product type segmentation, Bacterial Autogenous Vaccines was predicted to show maximum market share in the year 2023

Based on application segmentation, Livestock Vaccines was the leading type in 2023

Based on end-user segmentation, Veterinary Hospitals was the leading type in 2023

Based on distribution segmentation, Direct Sales was the leading type in 2023

On the basis of region, Europe was the leading revenue generator in 2023

Autogenous Vaccines Market- Segmentation Analysis:

The Global Autogenous Vaccines Market is segmented on the basis of Product Type, Application, Distribution, Technology, End User, and Region.

The market is divided into three categories based on application: Livestock Vaccines, Companion Animal Vaccines, and Aquaculture Vaccines. To effectively manage disease threats, large-scale farming operations with significant populations of cattle or poultry need to implement specialized vaccination programs. Large farms looking to improve biosecurity protocols and guarantee sustainable farming practices are especially likely to implement customized immunization strategies.

The market is divided into three categories based on product type: Bacterial Autogenous Vaccines, Viral Autogenous Vaccine, and Others. With more than 80% of the market, the bacterium segment of the autogenous vaccine market for fish farming led the way in 2023. Since bacteria like Aeromonas, Streptococcus, and Vibrio are frequently the cause of illness, there is a growing demand for vaccines specifically designed to combat these issues. Because they are specifically designed to combat the microorganisms present in a particular fish farm, autogenous vaccines are unique. They are therefore excellent at halting illnesses. Fish growers have come to love these vaccines because of how quickly they can be manufactured and used.

Autogenous Vaccines Market- Geographical Insights

Due to rising research efforts in the veterinary biologics and medicine industries and rising costs associated with providing animal healthcare, Europe is currently leading the world market for autogenous vaccines. Additionally, the market has grown as a result of the rising use of animal vaccines and rising awareness of animal health. Furthermore, Asia Pacific is among the most lucrative regions and is creating opportunities for international firms. The need for autogenous vaccines may rise in these areas due to the rising risk of infectious diseases and the high population of sick animals.

Autogenous Vaccines Market- Competitive Landscape:

Key Players in the Autogenous Vaccines Market include IDT Biologika GmbH, MARINNOVAC, Ceva Biovac, HIPRA, AniCon Labor GmbH, Kennebec River Biosciences etc. To improve their position in the industry, major competitors are concentrating on tactics including collaborations, product launches, mergers and acquisitions, and expansions. To serve a wider client base, businesses such as Newport Laboratories and others are, for instance, diversifying their product offerings and reaching out to new demographics. Major players like Ceva Sante Animale, Phibro Animal Health, and Zoetis are prominent due to their extensive research and development capabilities and broad distribution networks. Local and regional manufacturers also play a crucial role, particularly in regions with high livestock populations and specific disease challenges. These players often deeply understand local disease prevalence and tailor their solutions accordingly.

Recent Developments:

In February 2021, Philippe Mauguin, CEO of INRAE, and Dr. Marc Prikazsky, Chairman & CEO of Ceva Sante Animale, signed a first framework agreement to consolidate their collaboration in animal health.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL AUTOGENOUS VACCINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

IDT Biologika GmbH

MARINNOVAC

Ceva Biovac

Zoetis (PHARMAQAS)

Vaxxinova

Barramundi Asia Pte Ltd. (UVAXX Asia)

HIPRA

AniCon Labor GmbH

sanphar (ipeve)

Kennebec River Biosciences

Others

GLOBAL AUTOGENOUS VACCINES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Bacterial Autogenous Vaccines
  • Viral Autogenous Vaccine
  • Others

GLOBAL AUTOGENOUS VACCINES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Livestock Vaccines
  • Companion Animal Vaccines
  • Aquaculture Vaccines

GLOBAL AUTOGENOUS VACCINES MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2019 - 2032

  • Direct Sales
  • Distributor Sale
  • Online Sale

GLOBAL AUTOGENOUS VACCINES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines

GLOBAL AUTOGENOUS VACCINES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Veterinary Clinic
  • Veterinary Hospitals
  • Animal Farms
  • Aquaculture Farms

GLOBAL AUTOGENOUS VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Autogenous Vaccines Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Autogenous Vaccines Market Snippet by Product Type
    • 2.1.2. Autogenous Vaccines Market Snippet by Application
    • 2.1.3. Autogenous Vaccines Market Snippet by Distribution
    • 2.1.4. Autogenous Vaccines Market Snippet by Technology
    • 2.1.5. Autogenous Vaccines Market Snippet by End User
    • 2.1.6. Autogenous Vaccines Market Snippet by Country
    • 2.1.7. Autogenous Vaccines Market Snippet by Region
  • 2.2. Competitive Insights

3. Autogenous Vaccines Key Market Trends

  • 3.1. Autogenous Vaccines Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Autogenous Vaccines Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Autogenous Vaccines Market Opportunities
  • 3.4. Autogenous Vaccines Market Future Trends

4. Autogenous Vaccines Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Autogenous Vaccines Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Autogenous Vaccines Market Landscape

  • 6.1. Autogenous Vaccines Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Autogenous Vaccines Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Bacterial Autogenous Vaccines
    • 7.1.3. Viral Autogenous Vaccine
    • 7.1.4. Others

8. Autogenous Vaccines Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Livestock Vaccines
    • 8.1.3. Companion Animal Vaccines
    • 8.1.4. Aquaculture Vaccines

9. Autogenous Vaccines Market - By Distribution

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution, 2023 & 2032 (%)
    • 9.1.2. Direct Sales
    • 9.1.3. Distributor Sale
    • 9.1.4. Online Sale

10. Autogenous Vaccines Market - By Technology

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 10.1.2. Inactivated Vaccines
    • 10.1.3. Live Attenuated Vaccines
    • 10.1.4. Subunit Vaccines
    • 10.1.5. Toxoid Vaccines

11. Autogenous Vaccines Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 11.1.2. Veterinary Clinic
    • 11.1.3. Veterinary Hospitals
    • 11.1.4. Animal Farms
    • 11.1.5. Aquaculture Farms

12. Autogenous Vaccines Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Autogenous Vaccines Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Autogenous Vaccines Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. Italy
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.5. Italy Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.10.6. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.10.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. United Kingdom
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.5. United Kingdom Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.11.6. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.11.7. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. France
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.5. France Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.12.6. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.12.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Russia
      • 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Russia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. Netherlands
      • 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.4. Netherlands Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.14.5. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.14.6. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Poland
      • 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Poland Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Rest of Europe
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Rest of the Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Autogenous Vaccines Key Manufacturers in Asia Pacific
    • 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 12.4.7. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.8. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. India
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.5. India Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.9.6. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.9.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. China
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.5. China Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.10.6. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.10.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Thailand
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Thailand Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Indonesia
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Indonesia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America
    • 12.5.1. Overview
    • 12.5.2. Autogenous Vaccines Key Manufacturers in Latin America
    • 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.6. Latin America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 12.5.7. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.8. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Autogenous Vaccines Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Autogenous Vaccines Industry

  • 13.1. Competitive Dashboard
  • 13.2. Company Profiles
    • 13.2.1. IDT Biologika GmbH
    • 13.2.2. MARINNOVAC
    • 13.2.3. Ceva Biovac
    • 13.2.4. Zoetis (PHARMAQAS)
    • 13.2.5. Vaxxinova
    • 13.2.6. Barramundi Asia Pte Ltd. (UVAXX Asia)
    • 13.2.7. HIPRA
    • 13.2.8. AniCon Labor GmbH
    • 13.2.9. sanphar (ipeve)
    • 13.2.10. Kennebec River Biosciences
    • 13.2.11. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제